Porphyrin-acridine Hybrid Compounds as Potential Candidates for Topoisomerase II Alpha Inhibitors
Hubbi Nashrullah Muhammad, Sophi Damayanti and Daryono Hadi Tjahjono* Author for corresponding; e-mail address: hubbi@fa.itb.ac.id
Volume: Vol.47 No.3 (May 2020)
Research Article
DOI:
Received: 13 August 2019, Revised: -, Accepted: 3 December 2019, Published: -
Citation: Muhammad H.N., Damayanti S. and Tjahjono D.H., Porphyrin-acridine Hybrid Compounds as Potential Candidates for Topoisomerase II Alpha Inhibitors, Chiang Mai Journal of Science, 2020; 47(3): 455-472.
Abstract
Topoisomerase IIα plays a vital role in regulating DNA replication and transcription, and ensuring the successful unfolding, segregation, and condensation of chromosomes during mitosis. Because of its crucial function, it has become the target of several anticancer drugs that seek to disrupt the cell cycle of cancerous cells. In this study, we explored the potential for porphyrin-acridine hybrid compounds in inhibiting Topoisomerase IIα. We have designed porphyrin-acridine compounds with varying meso-substituents, and modeled their interactions with Topoisomerase IIα through molecular docking and molecular dynamics simulations. The porphyrin-acridine compounds interacted with the DNA at the Topoisomerase-DNA cleavage complex through intercalation and groove binding, assisted by strong hydrogen bonds and hydrophobic interactions. Molecular dynamics simulations show that mono-H2PyP-AC and bis-H2PzP-AC formed stable complexes with their targets. Binding free energy calculations also show that electrostatic interactions formed by the cationic meso substituents contributed to the overall interaction, and that the acridine moiety significantly strengthened the bond between ligand and target.